HEPATOCELLULAR CARCINOMA NON-RESECTABLE
Clinical trials for HEPATOCELLULAR CARCINOMA NON-RESECTABLE explained in plain language.
Never miss a new study
Get alerted when new HEPATOCELLULAR CARCINOMA NON-RESECTABLE trials appear
Sign up with your email to follow new studies for HEPATOCELLULAR CARCINOMA NON-RESECTABLE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo attack on tough liver tumors
Disease control Recruiting nowThis study is testing whether combining two immunotherapy drugs (durvalumab and tremelimumab) with a targeted internal radiation treatment (Y-90 SIRT) is safe and effective for people with intermediate-stage liver cancer that cannot be removed by surgery. The goal is to see if th…
Matched conditions: HEPATOCELLULAR CARCINOMA NON-RESECTABLE
Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated Apr 01, 2026 21:26 UTC
-
New Triple-Threat attack on tough liver cancer
Disease control Recruiting nowThis study is testing if adding a precise form of radiation (proton therapy) to a standard two-drug treatment can better control advanced liver cancer that cannot be removed by surgery. It will involve 45 patients to see if the combination is safe, slows cancer growth, and boosts…
Matched conditions: HEPATOCELLULAR CARCINOMA NON-RESECTABLE
Phase: PHASE2 • Sponsor: Chang Gung Memorial Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC